Abstract
Purpose
This study aimed to provide a better understanding of the impact of paclitaxel chemotherapy on breath alcohol in an Irish population.
Methods
Patients attending the Oncology Day Unit at Beaumont Hospital were invited to participate on the day of their treatment. The brand of paclitaxel used was Actavis Pharma Inc and contained 6 mg/mL paclitaxel in 50% Ethanol/ 50% Cremophor EL. Breath alcohol concentration was measured using the AlcoSense ™ Breathalyser on three separate visits. The primary end-point was the number of patients who were above the legal threshold for drink driving in Ireland.
Results
In total, 50 patients were recruited. 36 (68%) were female. The most common diagnosis was breast cancer (56%). Ten (20%) patients had metastatic disease and 4 (8%) had liver metastases. The mean paclitaxel dose administered was 118 mg. The mean amount of ethanol infused was 7.7 g. 27 patients had a detectable breath alcohol level on at least one visit. The mean breath alcohol concentration was 2 mcg/100 mL or 0.02 mg/L of breath. The maximum concentration of ethanol in exhaled breath was 11 mcg/100 mL or 0.11 mg/L which is 50% of the statutory limit for drink driving in Ireland. A weak correlation was observed between ethanol concentration in exhaled breath and the total amount of ethanol administered. Although no patient exceeded the general limit for drink driving in Ireland, three (6%) participants had a breath alcohol concentration above the threshold for professional, learner or novice drivers.
Conclusion
Although definitive conclusions are limited by relatively small numbers, it seems unlikely that weekly paclitaxel infusions pose any significant risk to patients driving.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author on request.
References
Mukhtar E, Adhami VM, Mukhtar H (2014) Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther 13(2):275–284
Donehower RC (1996) The clinical development of paclitaxel: a successful collaboration of academia, industry and the National Cancer Institute. Stem Cells 14(1):25–28
Joyce C (1993) Taxol: search for a cancer drug. Bioscience 43(3):133–136
Wilson DB, Beck TM, Gundlach CA (1997) Paclitaxel formulation as a cause of ethanol intoxication. Ann Pharmacother 31(7–8):873–875
Aomori T, Makino H, Sekizuka M, Hashita T, Araki T, Iizuka K et al (2012) Effect of ethanol in Paclitaxel injections on the ethanol concentration in exhaled breath. Drugs R&D 12(3):165–170
Komagata H, Yoneda S, Sakai H, Isobe K, Shirai T, Fujimura M et al (2006) Breath alcohol concentrations in Japanese outpatients following paclitaxel and docetaxel infusion. Int J Clin Pharmacol Res 25(4):195–202
Yamada Y, Sun F, Tsuritani I, Honda R (2002) Genetic differences in ethanol metabolizing enzymes and blood pressure in Japanese alcohol consumers. J Hum Hypertens 16(7):479–486
Yagi T, Fujiishi K, Hasegawa A, Otsuka T, Yoshinami T, Nishio M et al (2019) Aldehyde dehydrogenase 2 genotype in tolerability of alcohol contained in paclitaxel in Japanese breast cancer patients. Breast Cancer 26(2):229–234
Halim IIA, Ashri ME, Sadda WE (2011) Weekly paclitaxel versus standard 3-week schedule in patients with metastatic breast cancer. J Clin Oncol 29(15 suppl):627
Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF et al (2005) Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23(25):5983–5992
Generics T. Generic of taxol® injection 2007 https://www.tevagenerics.com/product/paclitaxel-injection-usp
Author N. https://www.medicines.org.uk/emc/files/pil.3891.pdf
NICE CfPHE. Review of effectiveness of laws limiting blood alcohol concentration levels to reduce alcohol-related road injuries and deaths March 2010. http://www.ias.org.uk/uploads/pdf/bloodalcoholcontenteffectivenessreview.pdf
Authority RS. Drink driving in Ireland 2018. https://www.drinkdriversdestroylives.ie
Library HND. New drink driving limits and penalties in Ireland. 2011. https://www.drugsandalcohol.ie/16883/
Sacco JJ, Botten J, Macbeth F, Bagust A, Clark P (2010) The average body surface area of adult cancer patients in the UK: a multicentre retrospective study. PLoS ONE 5(1):e8933
Jones AW (2010) The relationship between blood alcohol concentration (BAC) and breath alcohol concentration (BrAC): a review of the evidence. Road Safety Web Publication 15:1–43
Brunton LL, Lazo J, Parker KL (2011) Goodman and Gilman’s the pharmacological basis of therapeutics, 11th edn. Mc Graw-Hill, New York, pp 591–609
Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW et al (2001) Gender differences in pharmacokinetics of alcohol. Alcoholism Clin Exp Res 25(4):502–507
Moskowitz H, Fiorentino D (2000) A review of the literature on the effects of low doses of alcohol on driving-related skills. Report No: DOT HS 809 028. National Highway Traffic Safety Administration, Washington, DC
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by RJK, MM, KB, KE, LG, PGM, OSB. The first draft was written by RK and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Travel support: Patrick G. Morris, Roche, Novartis, Amgen; Honoraria: Patrick G. Morris, Astellas, Novartis, Pfizer, Teva, Nordic 2013, Bristol Meyers Squibb, Astra Zeneca, Genomic health, Roche; Consultancy or Advisory role: Patrick G. Morris, Novartis, Speaker Role: Patrick G. Morris, Teva; Research funding: Patrick G. Morris, Teva, Genomic Health.
Ethical approval
This study was approved by the Beaumont Hospital Institutional Review Board prior to study initiation. This study was performed in accordance with the Internal Conference on Harmonisation (ICH) for Good Clinical Practice (GCP) and the ethical principles founded in the Declaration of Helsinki.
Informed consent
All patients gave written informed consent to participate in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Keogh, R.J., Milewski, M., Browne, K. et al. An exploration of the impact of ethanol diluent on breath alcohol concentration in patients receiving paclitaxel chemotherapy. Cancer Chemother Pharmacol 88, 307–312 (2021). https://doi.org/10.1007/s00280-021-04279-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-021-04279-1